vimarsana.com

Latest Breaking News On - David risinger - Page 8 : vimarsana.com

Theravance Biopharma, Inc (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript

Theravance Biopharma, Inc. beats earnings expectations. Reported EPS is $0.03, expectations were $-0.04.

City ofUnited kingdomUnited statesRick winninghamDouglas tsaoTheravance biopharmaDavid risingerRhonda farnumAziz sawafHead of developmentTheravance biopharma incNational institutes of healthDepartment of neurosciencesCall transcript februaryTheravance biopharma fourth quarterChief executive

Experimental weight-loss drug from Viking Therapeutics could rival Ozempic, Mounjaro

Experimental weight-loss drug from Viking Therapeutics could rival Ozempic, Mounjaro
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.

Eli lillyEli lilly mounjaroDavid risingerNovo nordisk ozempicNovo nordiskDrug administrationViking therapeuticsLeerink partners

Experimental weight loss drug from Viking Therapeutics could rival Ozempic and Mounjaro

Viking Therapeutics has released results from an experimental drug that showed even better weight loss than current market-leading drugs, a sign that Ozempic

Eli lillyEli lilly mounjaroNovo nordisk ozempicDavid risingerNovo nordiskDrug administrationViking therapeuticsLeerink partners

VRTX Stock, IBD Stock Of The Day, Is Now Actionable — Here s Why

VRTX Stock, IBD Stock Of The Day, Is Now Actionable — Here s Why
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Maxim rahmanChristoper raymondPiper sandlerWilliam blairDavid risingerMyles minterPiper sandler raymondNaz rahmanVertex pharmaceuticalsDrug administrationMaxim groupCrispr therapeutics

Roivant Sciences Ltd (NASDAQ:ROIV) Q3 2023 Earnings Call Transcript

Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.3 EPS, expectations were $-0.27. Roivant Sciences Ltd.

Yaron werberAllison bratzelJoyce zhouDavid risingerMatt glineBrian chengPiper sandlerStephanie leeMayukh sukhatmeFastest growing energy companiesRoivant sciences ltdRoivant sciencesCall transcript februaryRoivant third quarterGrowing energy companiesUnfriendly countries

vimarsana © 2020. All Rights Reserved.